To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)
- Investigator
- Torge Rempe
- Status
- Accepting Candidates
- Ages
- 18 Years - 55 Years
- Sexes
- All
Update your location to show providers, locations, and services closest to you.
Neurologist
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)
The main objective of the study is to evaluate the efficacy of satralizumab compared with placebo based on time from randomization to the first occurrence of an adjudicated MOGAD relapse in the double-blind (DB) treatment period
Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis (PPMS) Secondary Objectives: To evaluate efficacy of SAR442168 compared to placebo on clinical…
23 publications
2024
Magnetic resonance imaging clinics of North America
PubMed • Publisher's site2024
Magnetic resonance imaging clinics of North America
PubMed • Publisher's site2023
Multiple Sclerosis and Related Disorders
Publisher's site2023
Medicine
Publisher's site2022
Journal of child neurology
PubMed • Publisher's site